X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (14) 14
earth drilling (11) 11
earth drilling, e.g. deep drilling (11) 11
fixed constructions (11) 11
mining (11) 11
obtaining oil, gas, water, soluble or meltable materials or aslurry of minerals from wells (11) 11
cancer (10) 10
bladder cancer (9) 9
mining or quarrying (9) 9
oncology (9) 9
female (7) 7
pathology (7) 7
prognosis (7) 7
basic electric elements (6) 6
bladder (6) 6
electric discharge tubes or discharge lamps (6) 6
electricity (6) 6
general tagging of cross-sectional technologies spanning over several sections of the ipc (6) 6
general tagging of new technological developments (6) 6
inductances (6) 6
magnets (6) 6
selection of materials for their magnetic properties (6) 6
technical subjects covered by former us classification (6) 6
technical subjects covered by former uspc (6) 6
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (6) 6
transformers (6) 6
aged (5) 5
animals (5) 5
breast-cancer (5) 5
gene expression (5) 5
male (5) 5
metastasis (5) 5
middle aged (5) 5
proteins (5) 5
signal transduction (5) 5
urinary bladder neoplasms - pathology (5) 5
biology (4) 4
biomarkers, tumor - metabolism (4) 4
cell line, tumor (4) 4
immunohistochemistry (4) 4
medicine (4) 4
multidisciplinary sciences (4) 4
patients (4) 4
protein (4) 4
research (4) 4
retrospective studies (4) 4
science (4) 4
tumors (4) 4
urinary bladder neoplasms - metabolism (4) 4
adult (3) 3
analysis (3) 3
biotechnology (3) 3
carcinoma, renal cell (3) 3
care and treatment (3) 3
chemotherapy (3) 3
cycle (3) 3
development and progression (3) 3
disease-free survival (3) 3
expression (3) 3
follow-up studies (3) 3
genetic aspects (3) 3
inhibition (3) 3
kinases (3) 3
metabolism (3) 3
mice (3) 3
multivariate analysis (3) 3
mutation (3) 3
pathway (3) 3
physiological aspects (3) 3
preservation (3) 3
protein binding (3) 3
radiotherapy (3) 3
risk factors (3) 3
signaling (3) 3
surgery (3) 3
tissue array analysis (3) 3
urinary bladder (3) 3
urinary bladder neoplasms - drug therapy (3) 3
urology (3) 3
aged, 80 and over (2) 2
antigens (2) 2
apoptosis (2) 2
autophagy (2) 2
binding (2) 2
biochemistry & molecular biology (2) 2
biophysics (2) 2
bioscience (2) 2
biotechnology & applied microbiology (2) 2
bladder cancer and urothelial neoplasias of the urinary tract (2) 2
calcium (2) 2
cancer therapies (2) 2
cancer treatment (2) 2
carcinoma in situ - pathology (2) 2
carcinoma, renal cell - metabolism (2) 2
carcinoma, renal cell - pathology (2) 2
cell (2) 2
cell cycle (2) 2
cell growth (2) 2
cell lines (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 1643 - 1643
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 1960 - 1960
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 1654 - 1654
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 3316 - 3316
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 3958 - 3958
Journal Article
Cancer Research, ISSN 0008-5472, 04/2010, Volume 70, Issue 8 Supplement, pp. 5405 - 5405
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 01/2019, Volume 152, Issue 1, pp. 26 - 30
To review outcomes of patients with stage III endometrial cancer confined to the pelvis treated with adjuvant pelvic radiotherapy (RT) or sequential... 
Chemotherapy | Endometrial cancer | Radiotherapy | Adjuvant therapy | Stage 3 | ONCOLOGY | NORMAL TISSUE | RADIATION | OBSTETRICS & GYNECOLOGY
Journal Article
Cancer biology & therapy, 04/2009, Volume 8, Issue 7, p. 6
Peroxisome Proliferator-Activated Receptors (PPARs) are ligand-activated intracellular transcription factors, members of the nuclear hormone receptor... 
Humans | PPAR gamma - agonists | Urinary Bladder Neoplasms - drug therapy | PPAR gamma - metabolism | Urinary Bladder Neoplasms - metabolism
Journal Article
International Journal for Vitamin and Nutrition Research, ISSN 0300-9831, 2018, Volume 88, Issue 1-2, pp. 27 - 38
Cardiovascular disease (CVD) risk factors, such as bad eating habits, are typical in adolescence and lead to the consumption of meals that are not always suffi... 
Antioxidant vitamins | Cardiovascular risk factors | Leptin | Adolescent | Polymorphism | ASSOCIATIONS | VARIANTS | Cardiovascular Risk Factors | CHILDREN | PERCENTILES | OBESITY | NUTRITION & DIETETICS | NUTRITIONAL DEFICIENCIES | WAIST CIRCUMFERENCE | BODY-MASS INDEX | RECEPTOR GENE | HYPERTENSION
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 04/2019, Volume 9, Issue 1, pp. 6348 - 9
Radical cystectomy (RC) together with bilateral pelvic lymph node dissection remains the standard treatment for muscle invasive bladder cancer (MIBC). However,... 
ANTICANCER CHEMOTHERAPY | PROTEIN | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | REGULATORY T-CELLS | RADIOTHERAPY | RADIOSENSITIVITY | AUTOPHAGY | GLYCYRRHIZIN | TUMOR MICROENVIRONMENT
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e65257
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2018, Volume 13, Issue 10, p. e0205746
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e55997
Background: Two signalling molecules that are attractive for targeted therapy are the epidermal growth factor receptor (EGFR) and the peroxisome... 
CARCINOMA-CELLS | GROWTH-FACTOR RECEPTOR | LUNG-CANCER | IN-VITRO | GEFITINIB | GENE | MULTIDISCIPLINARY SCIENCES | ACTIVATED-RECEPTOR-GAMMA | KINASE INHIBITORS | MUTATIONS | EXPRESSION | Receptor, Epidermal Growth Factor - genetics | Humans | Antineoplastic Agents - administration & dosage | PPAR gamma - metabolism | Dose-Response Relationship, Drug | Receptor, Epidermal Growth Factor - metabolism | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Female | Quinazolines - administration & dosage | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Drug Therapy, Combination | Urinary Bladder Neoplasms - metabolism | Disease Models, Animal | PPAR gamma - genetics | PTEN Phosphohydrolase - genetics | Gene Expression | CCAAT-Enhancer-Binding Protein-beta - genetics | PTEN Phosphohydrolase - metabolism | Urinary Bladder Neoplasms - drug therapy | CCAAT-Enhancer-Binding Protein-beta - metabolism | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Signal Transduction - drug effects | Tumor Burden - drug effects | PPAR gamma - agonists | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Protein Kinase Inhibitors - pharmacology | Quinazolines - pharmacology | Antimitotic agents | Care and treatment | Epidermal growth factor | Comparative analysis | Antineoplastic agents | Health aspects | Bladder cancer | Protein binding | Cancer | Cell proliferation | Therapy | Biotechnology | Crosstalk | Bladder | Oncology | Metastasis | Kinases | Cancer therapies | Urology | Angiogenesis | Signal transduction | Cell growth | Urinary bladder | Rodents | Transcription activation | Cell cycle | Inhibition | Gefitinib | Immunoglobulins | Epidermal growth factor receptors | Cyclin-dependent kinases | Tumor cell lines | Gene expression | Signaling | Cell lines | Diabetes | Mutation | Peroxisome proliferator-activated receptors | Tumors
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.